{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:57:16Z","timestamp":1776934636138,"version":"3.51.2"},"reference-count":44,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-069"],"award-info":[{"award-number":["2021-I2M-1-069"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: H007 is a novel selective AMP-activated protein kinase (AMPK) activator with demonstrated efficacy against hyperlipidemia; however, its oral bioavailability is limited by poor solubility and low intestinal permeability. This study aimed to develop a self-microemulsifying drug delivery system (SMEDDS) incorporating a H007\u2013phospholipid complex (H007-PC) to improve both solubility and intestinal permeability. Methods: H007-PC-SME was prepared by integrating phospholipid complexes into an SMEDDS formulation. The formulation was optimized on the basis of emulsification efficiency, droplet size, and zeta potential, and was then evaluated for stability, in vitro drug release, and cellular uptake. Different H007 formulations were orally administered to golden hamsters to assess bioavailability, and a chylomicron flow blockade hamster model was used to evaluate lymphatic transport. Results: The optimized H007-PC-SME showed good stability, rapid self-emulsification, and improved drug solubility. Relative to ordinary H007 tablets, the relative bioavailability of H007-SME and H007-PC-SME was 376.65% and 464.62%, respectively, when calculated from M1 exposure, and 314.01% and 463.55%, respectively, when calculated from MP exposure. When evaluated in a cycloheximide model, H007-SME and H007-PC-SME increased the lymphatic transport fraction of M1 from approximately 0% to 22% and 54%, and that of MP from approximately 1% to 28% and 52% compared with ordinary H007 tablets. Conclusions: H007-PC-SME combines stable phospholipid complex formation with strong self-emulsification performance and effective drug dissolution. By overcoming the intrinsic limitations of the H007 active pharmaceutical ingredient and ordinary H007 tablets, this formulation improves membrane permeability and lymphatic transport, thereby enhancing oral bioavailability and therapeutic potential. The formulation shows good stability and acceptable in vitro biocompatibility under the tested conditions. The preparation process is straightforward, reproducible, and suitable for further pharmaceutical development.<\/jats:p>","DOI":"10.3390\/pharmaceutics18040474","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:38:26Z","timestamp":1776080306000},"page":"474","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Evaluation of a Phospholipid Complex-Loaded SMEDDS for Enhanced Oral Delivery of H007, a Novel Anti-Hyperlipidemic Drug"],"prefix":"10.3390","volume":"18","author":[{"given":"Chunxi","family":"Liu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7585-8556","authenticated-orcid":false,"given":"Lundang","family":"Guo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqing","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Gong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunsheng","family":"Han","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7876-7007","authenticated-orcid":false,"given":"Song","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4139-4037","authenticated-orcid":false,"given":"Qingyun","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9149(02)02600-0","article-title":"Additive Effect of Plant Sterol-Ester Margarine and Cerivastatin in Lowering Low-Density Lipoprotein Cholesterol in Primary Hypercholesterolemia","volume":"90","author":"Simons","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2188\/jea.JE20140146","article-title":"Need for Better Blood Pressure Measurement in Developing Countries to Improve Prevention of Cardiovascular Disease","volume":"25","author":"Modesti","year":"2015","journal-title":"J. Epidemiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.104.515072","article-title":"Prevalence of Cardiovascular Disease Risk Factor Clustering Among the Adult Population of China: Results From the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia)","volume":"112","author":"Gu","year":"2005","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1501451","article-title":"Fresh Fruit Consumption and Major Cardiovascular Disease in China","volume":"374","author":"Du","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global Epidemiology of Dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100624","DOI":"10.1016\/j.lanepe.2023.100624","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: The multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/00325481.2022.2117498","article-title":"LDL-C Target Attainment in Secondary Prevention of ASCVD in the United States: Barriers, Consequences of Nonachievement, and Strategies to Reach Goals","volume":"134","author":"Underberg","year":"2022","journal-title":"Postgrad. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-511X-10-67","article-title":"A Novel AMPK Activator, WS070117, Improves Lipid Metabolism Discords in Hamsters and HepG2 Cells","volume":"10","author":"Lian","year":"2011","journal-title":"Lipids Health Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.08.012","article-title":"AMP-Activated Protein Kinase Attenuates oxLDL Uptake in Macrophages through PP2A\/NF-\u03baB\/LOX-1 Pathway","volume":"85","author":"Chen","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/jps.23258","article-title":"Species Difference of Esterase Expression and Hydrolase Activity in Plasma","volume":"101","author":"Bahar","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrd1344","article-title":"AMP Kinase and Malonyl-CoA: Targets for Therapy of the Metabolic Syndrome","volume":"3","author":"Ruderman","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"34182","DOI":"10.1074\/jbc.M204887200","article-title":"Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-Rich Very Low Density Lipoprotein Particles","volume":"277","author":"Grefhorst","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2010.01019.x","article-title":"Binding of Cordycepin Monophosphate to AMP-Activated Protein Kinase and Its Effect on AMP-Activated Protein Kinase Activation","volume":"76","author":"Wang","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1194\/jlr.M054742","article-title":"Inhibition of ABCA1 Protein Degradation Promotes HDL Cholesterol Efflux Capacity and RCT and Reduces Atherosclerosis in Mice","volume":"56","author":"Huang","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16594","DOI":"10.18632\/oncotarget.15027","article-title":"Comparative Transcriptomic Analysis of Mice Liver Treated with Different AMPK Activators in a Mice Model of Atherosclerosis","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sun, Y., Lian, Z., Jiang, C., Wang, Y., and Zhu, H. (2012). Beneficial Metabolic Effects of 2\u2032,3\u2032,5\u2032-Tri-Acetyl-N6- (3-Hydroxylaniline) Adenosine in the Liver and Plasma of Hyperlipidemic Hamsters. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032115"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jchromb.2016.04.004","article-title":"Simultaneous Quantification of 2\u2032,3\u2032,5\u2032-Tri-O-Acetyl-N6-(3-Hydroxylaniline)Adenosine and Its Principal Metabolites in Hamster Blood by LC\u2013MS\/MS and Its Application in Pharmacokinetics Study","volume":"1022","author":"Jia","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109980","DOI":"10.1016\/j.msec.2019.109980","article-title":"Statistical Approach for Solidifying Ticagrelor Loaded Self-Microemulsifying Drug Delivery System with Enhanced Dissolution and Oral Bioavailability","volume":"104","author":"Na","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/acs.molpharmaceut.9b00964","article-title":"Pharmacokinetic\/Pharmacodynamic Modeling To Predict the Antiplatelet Effect of the Ticagrelor-Loaded Self-Microemulsifying Drug Delivery System in Rats","volume":"17","author":"Na","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jphp.13021","article-title":"Self-Emulsifying Drug Delivery Systems and Cationic Surfactants: Do They Potentiate Each Other in Cytotoxicity?","volume":"71","author":"Lam","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhou, H., Wan, J., Wu, L., Yi, T., Liu, W., Xu, H., and Yang, X. (2013). A New Strategy for Enhancing the Oral Bioavailability of Drugs with Poor Water-Solubility and Low Liposolubility Based on Phospholipid Complex and Supersaturated SEDDS. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0084530"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.apsb.2014.03.002","article-title":"Combined Use of Phospholipid Complexes and Self-Emulsifying Microemulsions for Improving the Oral Absorption of a BCS Class IV Compound, Baicalin","volume":"4","author":"Wu","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1208\/s12249-018-1252-4","article-title":"Drug-Phospholipid Complex\u2014A Go Through Strategy for Enhanced Oral Bioavailability","volume":"20","author":"Kuche","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Huang, J., Chen, P.X., Rogers, M.A., and Wettig, S.D. (2019). Investigating the Phospholipid Effect on the Bioaccessibility of Rosmarinic Acid-Phospholipid Complex through a Dynamic Gastrointestinal in Vitro Model. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11040156"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejps.2016.12.012","article-title":"Emodin Self-Emulsifying Platform Ameliorates the Expression of FN, ICAM-1 and TGF-\u03921 in AGEs-Induced Glomerular Mesangial Cells by Promoting Absorption","volume":"99","author":"Huang","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00049-4","article-title":"Microemulsion Formulation for Enhanced Absorption of Poorly Soluble Drugs","volume":"81","author":"Kawakami","year":"2002","journal-title":"J. Control. Release"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(98)00054-4","article-title":"Formulation Design and Bioavailability Assessment of Lipidic Self-Emulsifying Formulations of Halofantrine","volume":"167","author":"Khoo","year":"1998","journal-title":"Int. J. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1208\/s12249-010-9385-0","article-title":"Preparation and Bioavailability Assessment of SMEDDS Containing Valsartan","volume":"11","author":"Dixit","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103778","DOI":"10.1016\/j.sjbs.2023.103778","article-title":"Omega-3 Fatty Acid-Based Self-Microemulsifying Drug Delivery System (SMEDDS) of Pioglitazone: Optimization, in Vitro and in Vivo Studies","volume":"30","author":"Emad","year":"2023","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10837450903499333","article-title":"Enhancement of Oral Bioavailability of Atorvastatin Calcium by Self-Emulsifying Drug Delivery Systems (SEDDS)","volume":"16","author":"Kadu","year":"2011","journal-title":"Pharm. Dev. Technol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/10717544.2011.604686","article-title":"Development of Optimized Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) of Carvedilol with Enhanced Bioavailability Potential","volume":"18","author":"Singh","year":"2011","journal-title":"Drug Deliv."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1211\/jpp.58.9.0004","article-title":"Preparation and Evaluation of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Containing Atorvastatin","volume":"58","author":"Shen","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2015.05.017","article-title":"Preparation and Evaluation of Kaempferol\u2013Phospholipid Complex for Pharmacokinetics and Bioavailability in SD Rats","volume":"114","author":"Zhang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/0250-474X.159596","article-title":"Role of Components in the Formation of Self-Microemulsifying Drug Delivery Systems","volume":"77","author":"Gurram","year":"2015","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.carbpol.2015.03.077","article-title":"Formulation and Process Optimization of Naproxen Nanosuspensions Stabilized by Hydroxy Propyl Methyl Cellulose","volume":"127","author":"Mishra","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40005-018-00417-9","article-title":"Formulation and Statistical Analysis of an Herbal Medicine Tablet Containing Morus Alba Leaf Extracts","volume":"49","author":"Son","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jsps.2014.11.001","article-title":"Self Nanoemulsifying Drug Delivery System of Stabilized Ellagic Acid\u2013Phospholipid Complex with Improved Dissolution and Permeability","volume":"23","author":"Avachat","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.9721\/KJFST.2015.47.5.561","article-title":"Effect of addition of egg yolk lecithin on the lipid oxidation of a water\/canola oil emulsion","volume":"47","author":"Choe","year":"2015","journal-title":"Korean J. Food Sci. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Son, G.-H., Na, Y.-G., Huh, H.W., Wang, M., Kim, M.-K., Han, M.-G., Byeon, J.-J., Lee, H.-K., and Cho, C.-W. (2019). Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11050222"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bang, K.-H., Na, Y.-G., Huh, H.W., Hwang, S.-J., Kim, M.-S., Kim, M., Lee, H.-K., and Cho, C.-W. (2019). The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane. Cancers, 11.","DOI":"10.3390\/cancers11060807"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2013.01.070","article-title":"A New Function of Vitamin E-TPGS in the Intestinal Lymphatic Transport of Lipophilic Drugs: Enhancing the Secretion of Chylomicrons","volume":"445","author":"Fan","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2008.07.003","article-title":"Intestinal Lymphatic Transport of Halofantrine in Rats Assessed Using a Chylomicron Flow Blocking Approach: The Influence of Polysorbate 60 and 80","volume":"35","author":"Lind","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2004.12.006","article-title":"Evaluation of a Chylomicron Flow Blocking Approach to Investigate the Intestinal Lymphatic Transport of Lipophilic Drugs","volume":"24","author":"Dahan","year":"2005","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/4\/474\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:17:14Z","timestamp":1776932234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/4\/474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["pharmaceutics18040474"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18040474","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}